Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP

Piggott, L., Silva, A., Robinson, T., Santiago-Gomez, A., Simoes, B. M., Becker, M., Fichtner, I., Anděra, L., Young, P., Morris, C., Barrett-Lee, P., Alchami, F., Piva, M., Vivanco, M. D., Clarke, R. B., Gee, J., Clarkson, R. Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP. Clinical Cancer Research. 2018, 24(10), 2452-2463. ISSN 1078-0432. E-ISSN 1557-3265. Available: doi: 10.1158/1078-0432.CCR-17-1381